Hi..... My name is Russ we talked before Dan went to Milwaukee. I lost your number and couldn't call you back....**.

duodopa
 

[QUOTE=Conductor71;567959]Duodopa has been used, quite successfully I understand, for four years now in 12 European countries. The Swedish have perfected the pump system, and the concept of an infusion was tested back in the 80's- this is hardly a new ideal.

From NPF:

Twenty-one years later, the medication called duodopa, administered into an area of the small intestine called the duodenum, is still in clinical trial in the United States.

What is annoying is that it's taken over 20 years for a pharamaceutical company to actually develop this therapy. I suspect it's because pharma didn't think this would compete with oral Sinemet, despite the evidence that a continuous infusion greatly reduces dyskinesia and on/off effects- really it's better for us over all. Now that Solvay sees a market in this treatment, I'm guessing it's the FDA bureaucracy holding things up? Anyone know the story behind this treatment?

Laura[/QUOTE

Since the subject came up again, and I didnt see this until now, I will tell you what I know (2 years later) but still might be news. I was invited to a couple of meeings with Solvay executives to discuss their FDA issues which I attended with our FDA consultant Tony DeCamp..This seems to be a case of total misguided heavy handed, mindless regulatory procedure, but I only heard one side. At the first meeting just after they had met with FDA, Solvey's director of R&D was miffed that the FDA would make a rigid requirement for a phase 1 safety test, followed by a phase 2 placebo controlled trial for a treatment where there is such a history and the active ingrdient is sinemet. It was treated as if it was a totally new therapy with no track record. We advised Solvay that it would be difficult to blind Patients from the effects of sinement, and suggested a crossover design that proved to be satifactory for Solvey who was about to pull the plug on the whole project, leaving patients without the option of this therapy,but continued at that time. However I have heard that they did sell out their rights and the placebo controlled trial is still recruiting. chalk one up for rigid regulation.

We think that intellient patient consultants in the meeting withn FDA might make a difference by giving the FDA and the company a way to compromise for the patient's interests, and problem solve on the need for hard data not readily available from therapies approved in Europe.

perry

This borders on being inhumane
 

[QUOTE=Perryc;743035]Laura here. Hugs to you for finding this and reporting...this is indeed news! Paula has been inquiring on this also and we have Jim who is ready to establish residency in Europe for treatment. I say that I have to agree with R& D at Solvay it is an absolute outrage that the FDA is treating them as if this were a new drug and I hope I can say I wonder where Medtronic fits into the picture. I have only been diagnosed for three years, age 43 with a 2 year old boy, and all I hear every six months is how I do not show any sign of Parkinsonism on Sinemet but to prepare myself for DBS in a year or two!?!? I may appear normal but have to dose every two hours to keep it that way, and frankly some days my MDS makes a lot of sense with his mantra. Clearly there is a huge market for a less invasive alternative.

I am very near starting an electronic petition here in the states and an information campaign. Sanjay Gupta and MJF should be discussing this on CNN. Where is the focus on the needs of more advanced patients in the here and now? This is so unbelievable to me. Anyway, I am on the verge of civil disobedience, but if there is any way I can become directly involved in promoting Solvay's efforts, please PM me. Also, who might I contact at Solvay for their perseverance and willingness to even attempt establishing a market here and giving us a much needed alternative- suppose I could just track down someone on web site but it is so much better to reach the right person.

Laura

Hi everyone. I'm new to the board, having started looking for more information about the clinical trial my father's starting at the end of the month for Duodopa via pump . . . Thank you all for sharing your success stories and frustrations. I would love to see pictures of some of the custom "rigs" people have devised to carry the pump more comfortably. I hope that everyone is well.

Thanks again,
Alison

Can someone do a video?
 

Perhaps one of you in the trials can get someone in your family to do a you tube type video that we could post on the web for others to check out. Off and then on with the pump, not too complex just shows the effects of the medication.

Wife Just Entered 003 Open Label Duodopa Trial
 

My wife was diagnosed 14 years ago with PD and just turned 60. For the past three months we have been participating in the 002 double blind Duodopa clinical trial with the University of Cincinnati. Just over a week ago my wife began the 003 open label phase that uses the active gel.

After reading the posts in this thread I feel like I should add my $0.02.

My wife was patient 8 of 10 at this site. Patients 9 and 10 have been fitted with tubes and are both just entering the 002 blind phase. As I understand it UC will admit no more patients, their quota is filled. But as I also understand it, other sites may still have openings to fulfill the 64 patient number nationwide.

My wife has experienced some mild discomfort at the stoma site but nothing major. As someone else mentioned, the tube that is used is a European design that does not work well and it prone to problems (the tube had to be reinserted once due to a knot during the 12 week trial, a common problem as it turns out) but the tube design must be used on all 002 patients while the trial is ongoing. The US version of the tube may be used at a later date but that has not been approved at this time.

We had always been told that my wife was a prime candidate for DBS but that option always seemed extreme and risky to us. Luckily for us, the DBS surgeon that cared for my wife happened to mention the Duodopa trial as we had told him we would NEVER resort to DBS.

All I can say is this, I have my wife back after only 10 days on the active gel. She is happy and hopeful again, smiles, her dyskinesia is almost non-existent and will be completely gone once we find the correct dosage and rate, she walks perfectly, and her cognitive abilities are returning too. It is not perfect but it is very close, a massive improvement over oral Sinemet.

This treatment works, simple as that. We are both very thankful for the gift we have been given and indebted to everyone at UC that worked so tirelessly to make this a success.